CLINICAL-TRIALS TO EVALUATE COST-EFFECTIVENESS

被引：6

作者：

HILLMAN, BJ

KAHAN, JP

NEU, CR

HAMMONS, GT

机构：

[1] RAND CORP,SANTA MONICA,CA 90406

[2] PHYSICIAN PAYMENT REVIEW COMMISS,WASHINGTON,DC

来源：

关键词：

D O I：

10.1097/00004424-198902000-00018

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

引用

页码：167 / 171

页数：5

共 18 条

[1]

BARSAMIAN EM, 1977, COSTS RISKS BENEFITS, P212

[2]

BUNKER JP, 1977, COSTS RISKS BENEFITS

[3]

CHALMERS TC, 1974, MT SINAI J MED, V41, P753

[4] THE CLINICAL-TRIAL [J].

CHALMERS, TC .

MILBANK MEMORIAL FUND QUARTERLY-HEALTH AND SOCIETY, 1981, 59 (03) :324-339

[5] SORTING OUT THE DOCTORS BAG [J].

FREDRICKSON, DS .

CONTROLLED CLINICAL TRIALS, 1980, 1 (03) :263-267

[6]

Gordon R. S., 1985, IRB REV HUMAN SUBJEC, V7, P12

[7]

Gordon Robert S, 1985, IRB, V7, P1, DOI 10.2307/3563887

[8] EVALUATING THE BENEFIT OF CLINICAL-TRIALS TO FUTURE PATIENTS [J].

HAWKINS, BS .

CONTROLLED CLINICAL TRIALS, 1984, 5 (01) :13-32

[9] PROTECTING MEDICAL COMMONS - WHO IS RESPONSIBLE [J].

HIATT, HH .

[10]

Jolly P, 1988, JAMA, V260, P1077